Metformin and Rapamycin Interaction
Metformin and Rapamycin have a synergistic interaction with 95% confidence. Metformin and rapamycin target complementary longevity pathways. Metformin activates AMPK while rapamycin directly inhibits mTOR. Preclinical studies in mice show the combination extends lifespan more than either compound alone. Some longevity-focused clinicians prescribe both concurrently, though human clinical trial data for the combination is limited. These compounds primarily affect different organ systems.
Compound Profiles
Metformin
Biguanide | AMPK Activator & Longevity Research
Metformin exerts its primary effects through activation of AMP-activated protein kinase (AMPK), the cell's master energy sensor. AMPK activation triggers a cascade of downstream metabolic improvements: enhanced glucose uptake in skeletal muscle, suppression of hepatic gluconeogenesis, improved mitochondrial function, and increased fatty acid oxidation.
View full profileRapamycin
mTOR Inhibitor | Longevity & Immunosuppression
Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take Metformin with Rapamycin?
Yes, Metformin and Rapamycin can generally be taken together. Metformin and rapamycin target complementary longevity pathways. Metformin activates AMPK while rapamycin directly inhibits mTOR. Preclinical studies in mice show the combination extends lifespan more than either compound alone. Some longevity-focused clinicians prescribe both concurrently, though human clinical trial data for the combination is limited.
Is Metformin and Rapamycin safe together?
Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between Metformin and Rapamycin?
Metformin and rapamycin target complementary longevity pathways. Metformin activates AMPK while rapamycin directly inhibits mTOR. Preclinical studies in mice show the combination extends lifespan more than either compound alone. Some longevity-focused clinicians prescribe both concurrently, though human clinical trial data for the combination is limited. This assessment has 95% confidence and is based on documented research data.
How should I time Metformin and Rapamycin?
Metformin has a half-life of ~5 hours and Rapamycin has a half-life of ~62 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.